Abstract
Dysregulation of the polyamine metabolism is common in different cancer types. SMOX is upregulated in hepatocellular carcinoma (HCC) but the relationship between SMOX and liver inflammation and fibrosis, remains unclear. In this issue of Clin Res Hepatol Gastroenterol, Hu and colleagues find targeting SMOX can alleviate liver cancer progression.
| Original language | English |
|---|---|
| Article number | 102429 |
| Journal | Clinics and Research in Hepatology and Gastroenterology |
| Volume | 48 |
| Issue number | 8 |
| DOIs | |
| State | Published - Oct 2024 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2024
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Fibrosis
- HCC
- Hepatocellular carcinoma
- Liver inflammation
- Polyamine metabolism
- SMOX
- Treatment
Fingerprint
Dive into the research topics of 'Targeting SMOX for the treatment of hepatocellular carcinoma?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver